All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Popularity bias in species selection threatens validity of comparative oncology research

By

Dujon, Antoine M., Courtalon, Jonas, Asselin, Klara, Thomas, Frédéric

13d ago· 35 min readenInsight

Summary

This article examines how scientific and public popularity of certain species introduces significant biases in comparative oncology research (the study of cancer risk variation across species). The authors demonstrate that popular, well-studied species (like those in zoos or with high public appeal) have disproportionately more cancer data available, skewing analyses of relationships between tumor prevalence and factors like body mass, longevity, and life-history traits. This popularity bias threatens the robustness of hypotheses about cancer defenses, conservation strategies, and the evolution of multicellularity. The research highlights a critical methodological flaw in comparative oncology that could lead to incorrect conclusions about cancer risk patterns across the animal kingdom.

Source

bskyPopularity bias in species selection threatens validity of comparative oncology researchdoi.org

Key quotes

· 3 pulled
Comparative oncology investigates variation in cancer risk across species by analysing relationships between observed tumour prevalence and factors such as body mass, longevity, life-history traits and mutation rates.
These patterns underpin hypotheses on cancer defences, conservation strategies and the evolution of multicellularity, so their robustness is critical.
Here, we show that species' scientific and public popularity substantially biases...
Snippet from the RSS feed
Abstract. Comparative oncology investigates variation in cancer risk across species by analysing relationships between observed tumour prevalence and facto

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.